Monte Rosa Therapeutics Inc (GLUE)
R&D Expense Growth
8.84%
Quarterly · Period ending:
GLUE R&D Expense Growth
Latest reported8.84%period ending
Latest reported8.84%period ending
GLUE Quarterly R&D Growth (QoQ) (0.00% → 8.84%)
Latest values, visible window
High-resolution chart · PNG
GLUE r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 8.8384% | |
| 4.9787% | |
| 14.4528% | |
| 19.6555% | |
| -4.7748% | |
| -17.177% | |
| 40.7373% | |
| 6.2358% | |
| 3.4462% | |
| -7.3927% | |
| -4.1369% | |
| -2.6482% | |
| 8.675% | |
| 7.5881% | |
| 16.5214% | |
| 1.9392% | |
| 16.863% | |
| -1.1859% | |
| 19.9471% | |
| 3.2657% | |
| 57.8454% | |
| -5.982% | |
| 80.2449% | |
| 12.7085% | |
| 27.2608% | |
| 0% |